|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/4035 | (2006.01) |
| (11) | Number of the document | 2276483 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08742326.5 |
| Date of filing the European patent application | 2008-03-27 | |
| (97) | Date of publication of the European application | 2011-01-26 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-07 |
| (46) | Date of publication of the claims translation | 2014-07-25 |
| (86) | Number | PCT/US2008/004021 |
| Date | 2008-03-27 |
| (87) | Number | WO 2009/120167 |
| Date | 2009-10-01 |
| (72) |
MULLER, George, W., US
SCHAFER, Peter, H., US
MAN, Hon-Wah, US
GE, Chuansheng, US
XU, Jean, US
|
| (73) |
CELGENE CORPORATION,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Solidinės formos, apimančios (+)-2-[1-(3-etoksi-4-metoksifenil)-2-metilsulfoniletil]-4-acetilaminoizoindolin-1,3-dioną, jų kompozicijos ir jų panaudojimas |
| SOLID FORMS COMPRISING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE, COMPOSITIONS THEREOF, AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2017-03-02 | 10 | 231.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2017-03-21 |